ArticleMedicine2026
Feasibility of 80-kVp CTA with reduced iodine contrast in chronic limb-threatening ischemia.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundComputed tomography angiography (CTA) is a vital preoperative diagnostic tool for chronic limb-threatening ischemia (CLTI). However, its high radiation dose and reliance on iodine contrast agents pose significant challenges, though studies addressing these challenges in CLTI remain limited. This study evaluates the feasibility of using 80-kVp tube voltage with reduced iodine contrast dosage in CTA for CLTI patients, aiming to minimize radiation exposure and contrast volume while preserving diagnostic image quality.
methodsA total of 74 CLTI patients were prospectively enrolled and divided into 2 groups: the experimental group (n = 37) underwent CTA at 80 kVp with a contrast injection rate of 3.5 mL/s and a total volume of 75 to 85 mL; the control group (n = 37) was scanned at 120 kVp with a contrast injection rate of 4.0 mL/s and a total volume of 95 to 105 mL. Parameters including radiation dose (volume computed tomography (CT) dose index and dose-length product), iodine intake, and image quality (CT attenuation values, noise, signal-to-noise ratio, contrast-to-noise ratio, and subjective scores) were compared.
resultsThe experimental group demonstrated a 19.4% reduction in iodine intake (P < .05) and a 30.1% and 29.3% reduction in volume computed tomography dose index and dose-length product, respectively (P < .05), compared with the control group. The experimental group demonstrated significantly higher CT attenuation values and increased image noise across all measured levels (all P < .05), while maintaining comparable signal-to-noise ratio across all measured levels (all P > .05). Similarly, contrast-to-noise ratio remained equivalent between groups at the lower abdominal aorta, mid-femoral artery, and mid-popliteal artery levels (all P > .05). The subjective image quality scores showed no significant differences between the experimental and control groups, both above (4.70 ± 0.46 vs 4.74 ± 0.44, P = .43) and below (4.08 ± 0.57 vs 4.15 ± 0.60, P = .15) the popliteal artery level.
conclusionLower-limb CTA using 80-kVp tube voltage and reduced iodine contrast dosage is feasible for CLTI patients, providing diagnostic image quality while significantly reducing radiation exposure and contrast volume. This approach offers a safer and more efficient alternative for preoperative evaluation in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.